Skip to main content
IL

Indee Labs

Indee Labs offers Hydropore™, a non-viral microfluidic technology that rapidly delivers small molecules, nucleic acids, and gene-editing complexes to immune cells, producing millions of high-quality cells with minimal impact on viability. This technology addresses the limitations of viral transduction and traditional transfection methods, streamlining the development and manufacturing of engineered cell therapies.

San Francisco, United StatesFounded 201581K+ followers
Updated 20 months ago

Funding

$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Engineering immune cells for cell therapies often relies on viral transduction or electroporation, which can be inefficient, damage cells, and raise safety concerns. These methods can limit the scalability and effectiveness of cell therapy development and manufacturing.

Solution

Indee Labs offers Hydropore™, a non-viral microfluidic technology that delivers molecules, nucleic acids, and gene-editing complexes to immune cells. Hydropore™ uses microfluidic vortex shedding to rapidly deliver payloads to cells, yielding millions to billions of high-quality cells while preserving cell viability and function. The technology bypasses the limitations of viral transduction and electroporation, accelerating cell therapy research from discovery to manufacturing.

Target Audience

The primary users are researchers and manufacturers in the field of engineered cell therapies, particularly those working with T-cell immunotherapies.

Features

  • Microfluidic vortex shedding (µVS) technology for rapid intracellular delivery
  • Non-viral method minimizes cell damage and safety risks
  • High cell viability and preserved cell function post-transfection
  • Scalable process suitable for research and manufacturing
  • Compatible with small molecules, nucleic acids, proteins, and gene-editing complexes
  • Suitable for high-throughput pooled screening of small volumes
  • Developed in an ISO 13485-compliant manner with medical-grade materials
This profile is AI-generated and may contain inaccuracies.